Eine riskante Entscheidung2022

Emily (8) is terminally ill. Her parents ask the new CEO of a small pharmaceutical company, Dr. Julia Schemmel, for the early release of a drug that is not yet ready for the market. Dr. Julia Schemmel is to consolidate the company. The young company has to invest hundreds of millions of euros for each drug and is planning to go public. At the same time, Michael and Nicole Wagner receive the diagnosis that their daughter is suffering from incurable childhood dementia. During extensive internet research, Michael finds out that the pharmaceutical company "Berner & Braun" is researching a cure that has already been tested on people in Asia. It is said to slow down the progression of the disease, possibly even stop it. Together with other affected parents, the Wagners demand a study for children in Germany and the release of the drug.